Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Victanyl 25micrograms/hour transdermal patches
0407020A0BMAAAE
|
Victanyl | Fentanyl | Central Nervous System | 128 |
|
Cynril 200microgram loz with integral oromucosal applicator
0407020A0BWAAAI
|
Cynril | Fentanyl | Central Nervous System | 116 |
|
Fentanyl 400microgram sublingual tablets sugar free
0407020A0AAAZAZ
|
Fentanyl | Fentanyl | Central Nervous System | 111 |
|
Victanyl 75micrograms/hour transdermal patches
0407020A0BMACAG
|
Victanyl | Fentanyl | Central Nervous System | 103 |
|
Abstral 300microgram sublingual tablets
0407020A0BJACAY
|
Abstral | Fentanyl | Central Nervous System | 87 |
|
Yemex 100micrograms/hour transdermal patches
0407020A0BVAEAH
|
Yemex | Fentanyl | Central Nervous System | 85 |
|
Effentora 400microgram buccal tablets
0407020A0BKACBE
|
Effentora | Fentanyl | Central Nervous System | 74 |
|
Abstral 800microgram sublingual tablets
0407020A0BJAFBB
|
Abstral | Fentanyl | Central Nervous System | 67 |
|
Abstral 600microgram sublingual tablets
0407020A0BJAEBA
|
Abstral | Fentanyl | Central Nervous System | 66 |
|
Victanyl 50micrograms/hour transdermal patches
0407020A0BMABAF
|
Victanyl | Fentanyl | Central Nervous System | 66 |
|
Victanyl 100micrograms/hour transdermal patches
0407020A0BMADAH
|
Victanyl | Fentanyl | Central Nervous System | 62 |
|
Yemex 75micrograms/hour transdermal patches
0407020A0BVADAG
|
Yemex | Fentanyl | Central Nervous System | 61 |
|
Fentanyl 800microgram lozenges
0407020A0AAALAL
|
Fentanyl | Fentanyl | Central Nervous System | 60 |
|
Victanyl 12micrograms/hour transdermal patches
0407020A0BMAEAU
|
Victanyl | Fentanyl | Central Nervous System | 56 |
|
PecFent 100micrograms/dose nasal spray
0407020A0BPAABJ
|
PecFent | Fentanyl | Central Nervous System | 52 |
|
Fentanyl 100micrograms/dose nasal spray
0407020A0AABJBJ
|
Fentanyl | Fentanyl | Central Nervous System | 46 |
|
Cynril 800microgram loz with integral oromucosal applicator
0407020A0BWADAL
|
Cynril | Fentanyl | Central Nervous System | 42 |
|
Fentanyl 300microgram sublingual tablets sugar free
0407020A0AAAYAY
|
Fentanyl | Fentanyl | Central Nervous System | 41 |
|
Cynril 400microgram loz with integral oromucosal applicator
0407020A0BWABAJ
|
Cynril | Fentanyl | Central Nervous System | 31 |
|
Fentanyl 800microgram sublingual tablets sugar free
0407020A0AABBBB
|
Fentanyl | Fentanyl | Central Nervous System | 31 |
|
Fentanyl 600microgram buccal tablets sugar free
0407020A0AABFBF
|
Fentanyl | Fentanyl | Central Nervous System | 30 |
|
Actiq 600microgram loz with integral oromucosal applicator
0407020A0BCACAK
|
Actiq | Fentanyl | Central Nervous System | 29 |
|
Actiq 800microgram loz with integral oromucosal applicator
0407020A0BCADAL
|
Actiq | Fentanyl | Central Nervous System | 26 |
|
Fentanyl 1.6mg lozenges
0407020A0AAAPAP
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
|
Fentanyl 600microgram sublingual tablets sugar free
0407020A0AABABA
|
Fentanyl | Fentanyl | Central Nervous System | 26 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.